GetTopicDetailResponse(id=771e5e3652b, topicName=放射性碘拮抗, introduction=放射性碘拮抗, content=null, image=null, comments=1, allHits=910, url=https://h5.medsci.cn/topic?id=57365, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=70539, tagList=[TagDto(tagId=70539, tagName=放射性碘拮抗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2032608, encodeId=ef36203260831, content=<a href='/topic/show?id=771e5e3652b' target=_blank style='color:#2F92EE;'>#放射性碘拮抗#</a>, objectTitle=卡博替尼有望成為放射性碘拮抗的甲狀腺癌一線治療藥物, objectType=article, longId=130632, objectId=0a5c130632d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a5c130632d4, replyNumber=0, likeNumber=115, createdTime=2018-11-23, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a5c130632d4, moduleTitle=卡博替尼有望成為放射性碘拮抗的甲狀腺癌一線治療藥物, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0a5c130632d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
